OKUR
insider transactionsOnKure Therapeutics, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
-387
0 buy · 387 sell
Net value · 365d
-$1.6K
$0 in · $1.6K out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
2
0 buy · 387 sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Director
$0
2.0K sh
Own New
-
Grant·A
Director
$0
3.8K sh
Own New
-
Grant·A
Director
$0
7.7K sh
Own New
-
Grant·A
Director
$0
1.3K sh
Own New
-
Grant·A
Director
$0
7.7K sh
Own New
-
Grant·A
Director
$0
7.7K sh
Own New
-
Grant·A
Director
$0
7.7K sh
Own New
-
Grant·A
Michael G Grey KEY
Executive Chairman
$0
1.7K sh
Own New
-
Grant·A
President and CEO
$0
330.0K sh
Own New
-
Grant·A
Chief Financial Officer
$0
110.0K sh
Own New
-
Grant·A
Chief Scientific Officer
$0
110.0K sh
Own New
-
Grant·A
Chief Medical Officer
$0
110.0K sh
Own New
-
Grant·A
Director
$0
15.3K sh
Own New
-
Sell·S
President and CEO
$357
86 sh · $4.16
Own -1%
-
Sell·S
Chief Financial Officer
$1.3K
301 sh · $4.16
Own -2%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 15, 2026 | Michael G Grey | Grant A | 2.0K | $0 |
| Jun 15, 2026 | Michael G Grey | Grant A | 3.8K | $0 |
| Jun 4, 2026 | Andrew John Phillips | Grant A | 7.7K | $0 |
| Jun 4, 2026 | Liam Ratcliffe | Grant A | 1.3K | $0 |
| Jun 4, 2026 | Valerie Malyvanh Jansen | Grant A | 7.7K | $0 |
| Jun 4, 2026 | Michael G Grey | Grant A | 7.7K | $0 |
| Jun 4, 2026 | Michael R Carruthers | Grant A | 7.7K | $0 |
| May 21, 2026 | Michael G Grey KEY | Grant A | 1.7K | $0 |
| Apr 1, 2026 | Nicholas A Saccomano KEY | Grant A | 330.0K | $0 |
| Apr 1, 2026 | Jason A. Leverone KEY | Grant A | 110.0K | $0 |
| Apr 1, 2026 | Dylan Hartley | Grant A | 110.0K | $0 |
| Apr 1, 2026 | Samuel Agresta | Grant A | 110.0K | $0 |
| Mar 31, 2026 | Liam Ratcliffe | Grant A | 15.3K | $0 |
| Mar 23, 2026 | Nicholas A Saccomano KEY | Sell S | 86 | $357 |
| Mar 23, 2026 | Jason A. Leverone KEY | Sell S | 301 | $1.3K |
About OKUR insider trading
This page tracks insider transactions for OnKure Therapeutics, Inc. (OKUR) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.